Literature DB >> 1103945

The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency.

K Breederveld, J C Giddings, J W ten Cate, A L Bloom.   

Abstract

Separation of human platelets from plasma by a modified gel-filtration technique reveals very low levels of factor-V activity of the platelet suspension. Repeated freezing and thawing increases the factor-V activity in various factor-V assays. This activity neutralized the inactivating effect of a rabbit-antihuman factor V antibody to plasma factor V, while intact platelets had almost no such capacity. Washed and normal platelets and gel filtered platelets showed marked positive fluorescence after treatment with antifactor V serum and FITC labelled sheep antirabbit immunoglobulin. Fluorescence was inhibited by previous incubation of the antifactor V serum and platelet lysates. Platelets of a factor V deficient patient showed the same fluorescence pattern as normal platelets indicating that they contained a factor V antigen. These platelets showed after lysis no effect in various factor V assays. From these studies it is concluded that the localization of factor V is within the platelets.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1103945     DOI: 10.1111/j.1365-2141.1975.tb01838.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Optimal techniques for the immunocytochemical demonstration of beta-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets.

Authors:  P E Stenberg; M A Shuman; S P Levine; D F Bainton
Journal:  Histochem J       Date:  1984-09

2.  Subcellular localization and secretion of factor V from human platelets.

Authors:  C M Chesney; D Pifer; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Biosynthesis of factor V in isolated guinea pig megakaryocytes.

Authors:  H C Chiu; P K Schick; R W Colman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Human coagluation factor V purification and thrombin-catalyzed activation.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

5.  Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.

Authors:  M S Lipscomb; P N Walsh
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.

Authors:  G M Rodgers; M A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

Authors:  J P Miletich; D W Majerus; P W Majerus
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Activation of coagulation factor V by a platelet protease.

Authors:  W H Kane; J S Mruk; P W Majerus
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Platelet C1- inhibitor. A secreted alpha-granule protein.

Authors:  A H Schmaier; P M Smith; R W Colman
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.